4.7 Article

Delayed Access and Survival in Idiopathic Pulmonary Fibrosis A Cohort Study

出版社

AMER THORACIC SOC
DOI: 10.1164/rccm.201104-0668OC

关键词

access to healthcare; healthcare disparities; idiopathic pulmonary fibrosis; interstitial lung disease; survival

资金

  1. NIH [K23 HL086714, KL2 RR024156]
  2. Robert Wood Johnson Physician Faculty Scholars Program
  3. Herbert and Florence Irving Scholar Award
  4. National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [KL2 RR024156]
  5. NIH Roadmap for Medical Research
  6. Bayer
  7. Gilead
  8. Pfizer
  9. American Lung Association
  10. Novartis
  11. Actelion
  12. United Therapeutics
  13. Lung Rx
  14. Merck
  15. Robert Wood Johnson Foundation

向作者/读者索取更多资源

Rationale: Idiopathic pulmonary fibrosis is often initially misdiagnosed. Delays in accessing subspecialty care could lead to worse outcomes among those with idiopathic pulmonary fibrosis. Objectives: To examine the association between delayed access to subspecialty care and survival time in idiopathic pulmonary fibrosis. Methods: We performed a prospective cohort study of 129 adults who met American Thoracic Society criteria for idiopathic pulmonary fibrosis evaluated at a tertiary care center. Delay was defined as the time from the onset of dyspnea to the date of initial evaluation at a tertiary care center. We used competing risk survival methods to examine survival time and time to transplantation. Measurements and Main Results: The mean age was 63 years and 76% were men. The median delay was 2.2 years (interquartile range 1.0-3.8 yr), and the median follow-up time was 1.1 years. Age and lung function at the time of evaluation did not vary by delay. A longer delay was associated with an increased risk of death independent of age, sex, forced vital capacity, third-party payer, and educational attainment (adjusted hazard ratio per doubling of delay was 1.3, 95% confidence interval 1.03 to 1.6). Longer delay was not associated with a lower likelihood of undergoing lung transplantation. Conclusions: Delayed access to a tertiary care center is associated with a higher mortality rate in idiopathic pulmonary fibrosis independent of disease severity. Early referral to a specialty center should be considered for those with known or suspected interstitial lung disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据